Skip to main content

Table 2 Proportion of patients with Response to chemotherapy

From: Concurrent and reactivation of hepatitis B virus infection in diffuse large B-cell lymphoma: risk factors and survival outcome

Response to chemotherapy Diffuse large B-cell lymphoma P value
HBsAg-positive HBsAg-negative
Sample size 80 166  
Response    <  0.001
 Complete response 29 (36.2%) 106 (63.9%)  
 Partial response 15 (18.8%) 28 (16.9%)  
 Stable disease 1 (1.2%) 2 (1.1%)  
 Progress disease 35 (43.8%) 30 (18.1%)